Now a third option is available after the U.S. Food and Drug Administration last week approved Vertex Pharmaceuticals’ Suzetrigine, sold as twice-daily Journavx, a non-addictive prescription drug for ...

A controversial campaign pledge to enact big, universal tariffs that would transform the global-trade system and usher in American prosperity has been whittled down to a set of hollow threats designed ...

Accurate pain reporting in sickle cell disease is critical to effective pain assessment and management, but accuracy depends on patient comprehension of forms.